# Alan G. Zimmermann

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alan-g-zimmermann/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,654 |
| Field | Growth Hormone and Insulin-like Growth Factors |
| h-index | 28 |
| i10-index | 32 |
| Last Known Institution | Eli Lilly (United States) |
| OpenAlex ID | https://openalex.org/A5113170261 |
| Works | 60 |

## Researcher papers

- [Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial](https://scholariq.org/papers/dulaglutide-versus-insulin-glargine-in-patients-with-type-2-diabetes-and/)
- [Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)](https://scholariq.org/papers/efficacy-and-safety-of-once-weekly-dulaglutide-versus-insulin-glargine-in/)
- [The epidemiology of neonatal tumours](https://scholariq.org/papers/the-epidemiology-of-neonatal-tumours/)
- [Prevalence of Metabolic Syndrome in Adult Hypopituitary Growth Hormone (GH)-Deficient Patients Before and After GH Replacement](https://scholariq.org/papers/prevalence-of-metabolic-syndrome-in-adult-hypopituitary-growth-hormone-gh/)
- [GH Treatment to Final Height Produces Similar Height Gains in Patients With SHOX Deficiency and Turner Syndrome: Results of a Multicenter Trial](https://scholariq.org/papers/gh-treatment-to-final-height-produces-similar-height-gains-in-patients-with-shox/)
- [Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients](https://scholariq.org/papers/prospective-safety-surveillance-of-gh-deficient-adults-comparison-of-gh-treated/)
- [Preliminary studies on the effectiveness of the novel pulicide, spinosad, for the treatment and control of fleas on dogs](https://scholariq.org/papers/preliminary-studies-on-the-effectiveness-of-the-novel-pulicide-spinosad-for-the/)
- [A Structural Taxonomy of Amateur Sport Organizations](https://scholariq.org/papers/a-structural-taxonomy-of-amateur-sport-organizations/)
- [Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program](https://scholariq.org/papers/safety-outcomes-during-pediatric-gh-therapy-final-results-from-the-prospective/)
- [Prevalence and Incidence of Diabetes Mellitus in GH-Treated Children and Adolescents: Analysis from the GeNeSIS Observational Research Program](https://scholariq.org/papers/prevalence-and-incidence-of-diabetes-mellitus-in-gh-treated-children-and/)
- [Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7)](https://scholariq.org/papers/body-weight-and-egfr-during-dulaglutide-treatment-in-type-2-diabetes-and/)

## Researcher topics

- [Growth Hormone and Insulin-like Growth Factors](https://scholariq.org/topics/growth-hormone-and-insulin-like-growth-factors/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pituitary Gland Disorders and Treatments](https://scholariq.org/topics/pituitary-gland-disorders-and-treatments/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

## Researcher university

- [Eli Lilly (United States)](https://scholariq.org/institutions/eli-lilly-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.